drugset
drugset / Trial / NCT01409018

Pharmacokinetics of Itraconazole in Pediatric Cancer Patients

NCT01409018 ↗

Phase 1 Completed 6 enrolled Seoul National University Hospital
NaSingle-groupOpen-labelTreatment

Summary

This study investigated repeated-dose pharmacokinetics and safety of itraconazole and its active metabolite hydroxyitraconazole in pediatric cancer patients at risk for the development of invasive fungal disease.

Timeline

Start
2009-06
Primary completion
2010-12
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Itraconazole Small molecule — —

Indications

childhood malignant neoplasm